CBFP
RGEN icon

Cedar Brook Financial Partners’s Repligen RGEN Stock Holding History

Cedar Brook Financial Partners’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-763
Closed -$220K – 392
2021
Q3 		$220K Buy
+763
New +$196K 0.07% 310

Other funds holding RGEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cedar Brook Financial Partners's RGEN Position: Q4 2021 in Review

Cedar Brook Financial Partners sold out of Repligen (RGEN) in Q4 2021, closing a stake of 763 shares — an estimated $220K sold.

Cedar Brook Financial Partners first reported a position in RGEN in Q3 2021 and held it in 1 quarter. The position peaked at $220K in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • Cedar Brook Financial Partners reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • Cedar Brook Financial Partners sold 763 Repligen shares in Q4 2021, an estimated $220K.
  • Cedar Brook Financial Partners first reported a position in Repligen in Q3 2021 and held it in 1 quarter.
  • Cedar Brook Financial Partners's Repligen position peaked at $220K in Q3 2021.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on Cedar Brook Financial Partners's 13F filing for Q4 2021, filed 27 Jan 2022.